Sciencelnsider explored why academic bio-medical scientists report that they are receiving less corporate support for their research now than in the 1990s. Possible reasons for the shift include the 5-year doubling of the National Institutes of Health budget and a public debate over whether funding from drug companies can distort research results.
展开▼
